SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
IREN Limited (IREN) trades at a trailing P/E of 19.5, forward P/E of 86.2. Trailing earnings yield is 5.12%, forward earnings yield 1.16%. PEG 2.11. Graham Number is $22.01.
Criteria proven by this page:
- VALUE (94/100, Pass) — P/E is below market average (19.5); analyst target implies upside (+64.9%); earnings yield beats bond yields (5.12%).
- PEG Ratio 2.11 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield 5.12% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
- Analyst consensus target $78.13 (+64.9% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 68/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
94/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — IREN
Valuation Multiples
P/E (TTM)19.5
Forward P/E86.2
PEG Ratio2.11
Forward PEG2.11
P/B Ratio3.13
P/S Ratio17.27
EV/EBITDA16.9
Per Share Data
EPS (TTM)$1.86
Forward EPS (Est.)$0.55
Book Value / Share$11.59
Revenue / Share$3.22
FCF / Share$-1.20
Yields & Fair Value
Earnings Yield5.12%
Forward Earnings Yield1.16%
Dividend Yield0.00%
Graham Number$22.01
SharesGrow IV$-28.59 (-160.4%)
Analyst Target$78.13 (+64.9%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2019 |
-2,473.0 |
0.00 |
227.66 |
378,401.78 |
- |
| 2020 |
-628.2 |
-2.16 |
220.24 |
618.97 |
- |
| 2021 |
-21.4 |
-0.01 |
-34.86 |
163.87 |
- |
| 2022 |
-0.3 |
0.00 |
0.31 |
2.32 |
- |
| 2023 |
-1.5 |
0.02 |
0.84 |
3.38 |
- |
| 2024 |
-43.5 |
0.48 |
1.15 |
6.72 |
- |
| 2025 |
36.0 |
-0.15 |
1.72 |
6.24 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2019 |
$-0.01 |
$1.05K |
$-161.12K |
-15301% |
| 2020 |
$-0.04 |
$2.17M |
$-2.13M |
-98% |
| 2021 |
$-1.07 |
$7.84M |
$-60.51M |
-772% |
| 2022 |
$-10.25 |
$59.04M |
$-419.77M |
-711% |
| 2023 |
$-3.14 |
$75.51M |
$-171.87M |
-227.6% |
| 2024 |
$-0.29 |
$188.76M |
$-28.96M |
-15.3% |
| 2025 |
$0.39 |
$501.02M |
$86.94M |
17.4% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$0.54 |
$0.22 – $0.87 |
$999.91M |
$949.32M – $1.06B |
6 |
| 2027 |
$0.74 |
$-0.38 – $2.92 |
$2.86B |
$2.65B – $3.07B |
9 |
| 2028 |
$2.08 |
$-2.85 – $12.97 |
$3.97B |
$3.02B – $4.67B |
4 |
| 2029 |
$-1.02 |
$-1.26 – $-0.70 |
$2.34B |
$1.78B – $2.75B |
1 |
| 2030 |
$-0.99 |
$-1.22 – $-0.68 |
$4.28B |
$3.25B – $5.04B |
1 |
